You are here
Progressive Care Announces Newly Redesigned Website for Wholly-Owned Subsidiary PharmCo, LLC
PharmCo’s New Website to Bring More Focus on Robust Offering of Telepharmacy Products and Services
MIAMI, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has launched an updated website for its wholly owned subsidiary, PharmCo, LLC, dedicated to providing their patients with additional knowledge on its growing platform of offered products and suite of services.
“As the company continues to grow, we want to provide significant updates that not only align with Progressive Care and Pharmco’s evolving business, but also provides patients with a better understanding of our products and services,” said S. Parikh Mars, CEO of Progressive Care Inc. “We are excited to not only expand our service capabilities but provide a resource platform for healthcare stakeholders to understand our company, our model and how we deliver leading performance and results.”
“The new PharmCo Rx website portal was built on the latest website technology, utilizing HTML5, Parallax Graphics and Responsive Design,” said Marcello Jaspan, CEO and President of Mass Ventures Corp. “We are proud of this accomplishment and humbled by the trust Progressive Care has placed on us for the past 6 years as their technology partners. Our next deployment and initiative is the release of PharmCo’s Tele-Pharmacy Platform and Kiosk Systems, currently undergoing final testing.”
The newly re-designed website now features more detailed information on the company’s offered services, such as:
To view the new PharmCo website, please visit www.pharmcopharmacy.com.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Public Relations Contact:
Tory Patterson, CMW Media
Web and Application Development Contact:
Marcello Jaspan, Mass Ventures Corp